Tsubota Laboratory Incorporated Logo

Tsubota Laboratory Incorporated

Developing pharmaceuticals and medical devices for ophthalmic and brain diseases.

4890 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区信濃町35 慶應義塾大学信濃町キャンパス2号館9階CRIK信濃町E7
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Tsubota Laboratory Incorporated is a bio-venture company that originated as a startup from Keio University. The firm is engaged in the research and development of innovative pharmaceuticals and medical devices. Its primary focus is on creating solutions for ophthalmic conditions such as myopia, dry eye, and presbyopia. The company also extends its research into treatments for brain diseases, including depression and dementia, notably exploring the application of technologies like violet light therapy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-27 04:35
Post-Annual General Meeting Information
臨時報告書
Japanese 23.3 KB
2025-06-26 09:02
Regulatory News Service
確認書
Japanese 9.4 KB
2025-06-26 09:01
Regulatory News Service
内部統制報告書-第13期(2024/04/01-2025/03/31)
Japanese 23.5 KB
2025-06-26 09:01
Annual Report
有価証券報告書-第13期(2024/04/01-2025/03/31)
Japanese 1.6 MB
2024-11-14 08:02
Regulatory News Service
確認書
Japanese 9.0 KB
2024-11-14 08:02
Interim Report
半期報告書-第13期(2024/04/01-2025/03/31)
Japanese 201.7 KB
2024-06-27 04:10
Governance Information
内部統制報告書-第12期(2023/04/01-2024/03/31)
Japanese 22.8 KB
2024-06-27 04:09
Regulatory News Service
確認書
Japanese 8.9 KB
2024-06-27 04:08
Annual Report
有価証券報告書-第12期(2023/04/01-2024/03/31)
Japanese 1.7 MB
2024-02-14 07:11
Report Publication Announcement
確認書
Japanese 9.0 KB
2024-02-14 07:10
Quarterly Report
四半期報告書-第12期第3四半期(2023/10/01-2023/12/31)
Japanese 160.1 KB
2023-11-13 07:06
Report Publication Announcement
確認書
Japanese 9.0 KB
2023-11-13 07:02
Quarterly Report
四半期報告書-第12期第2四半期(2023/07/01-2023/09/30)
Japanese 193.0 KB
2023-08-14 09:17
Report Publication Announcement
確認書
Japanese 9.0 KB
2023-08-14 09:16
Quarterly Report
四半期報告書-第12期第1四半期(2023/04/01-2023/06/30)
Japanese 153.7 KB

Automate Your Workflow. Get a real-time feed of all Tsubota Laboratory Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Tsubota Laboratory Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CARTA HOLDINGS, INC. Logo
Digital marketing firm offering ad platforms and integrated solutions to empower businesses.
Japan 3688
Celyad Oncology SA Logo
Clinical-stage biotech developing CAR T therapies for solid and blood cancers.
Belgium CYAD
CENTAUR MEDIA PLC Logo
Provides business intelligence, learning, and consultancy for marketing & legal professionals.
United Kingdom CAU
Cereno Scientific AB Logo
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
Sweden CRNO
CERES INC. Logo
Develops online media platforms connecting consumers with advertisers through a rewards system.
Japan 3696
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea 085660
An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.
South Korea 351870
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea 030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan 4583

Talk to a Data Expert

Have a question? We'll get back to you promptly.